Updated Guidelines Broaden Statin Eligibility for Millions of US Adults

Revised dyslipidemia guidelines from the American Heart Association and American College of Cardiology now recommend statin therapy for an additional 21.5 million U.S. adults. This expansion primarily targets younger, lower-risk individuals to prevent atherosclerotic cardiovascular disease. The new criteria mean a significant portion of the adult population, estimated at 87.5 million, is now eligible for primary prevention statin treatment.